Description
Multiple ASO programs failed, with the debate noting that complex RNA secondary structures resist binding, but the specific structural barriers weren’t characterized. Understanding this could enable next-generation RNA therapeutics.
Source: Debate session sess_SDA-2026-04-11-sda-2026-04-01-gap-006 (Analysis: SDA-2026-04-11-sda-2026-04-01-gap-006)